ABC | Volume 113, Nº3, Setembro 2019

Atualização Atualização da Diretriz de Ressuscitação Cardiopulmonar e Cuidados Cardiovasculares de Emergência da Sociedade Brasileira de Cardiologia – 2019 Arq Bras Cardiol. 2019; 113(3):449-663 1091. Albuquerque DC, Neto JD, Bacal F, Rohde LE, Bernardez-Pereira S, Berwanger O, et al; Investigadores Estudo BREATHE. I Brazilian Registry of heart failure - clinical aspects, care quality and hospitalization outcomes. Arq Bras Cardiol. 2015;104(6):433-42. 1092. Stevenson LW, Massie BM, Francis GS. Optimizing therapy for complex or refractory heart failure: a management algorithm. Am Heart J. 1998;135(6Pt 2 Su):S293-309. 1093. CanesinMF,Oliveira JrMT,Pereira-BarrettoAC. (editores).SAVIC-Suporte avançado de vida em insuficiência cardíaca. Rio de Janeiro: Med Line Editora Ltda; 2011. 1094. Chen Y, Chen P, Hanaoka M, Huang X, Droma Y, Kubo K. Mechanical ventilation in patients with hypoxemia due to refractory heart failure. Intern Med. 2008;47(5):367-73. 1095. Faris R, Flather MD, Purcell H, Poole-Wilson PA, Coats AJ. Diuretics for heart failure. Cochrane Database Syst Rev. 2006 Jan 25;(1):CD003838. 1096. Granada J, Uribe W, Chyou PH, Maassen K, Vierkant R, Smith PN, et al. Incidence and predictors of atrial flutter in the general population. J Am Coll Cardiol. 2000;36(7):2242-6. 1097. Adams KF Jr, Fonarow GC, Emerman CL, Lejemtel TH, Costanzo MR, Abraham WT, et al; ADHERE Scientific Advisory Committee and Investigators.Characteristicsandoutcomesofpatientshospitalizedforheart failure in theUnited States: rationale, design, and preliminary observations from the first 100.000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). AmHeart J. 2005;149(2):209-16. 1098. Benza RL, Tallaj JA, Felker GM, Zabel KM, Kao W, Bourge RC, et al; OPTIME-CHF Investigators. The impact of arrhythmias in acute heart failure. J Card Fail. 2004;10(4):279-84. 1099. Bocchi EA, Braga FG, Ayub-Ferreira SM, Rohde LE, OliveiraWA, Almeida DR, et al.; Sociedade Brasileira de Cardiologia. III Brazilian Guidelines on Chronic Heart Failure. Arq Bras Cardiol. 2009;93(1 Suppl 1):3-70. 1100. Bocchi EA, Marcondes-Braga FG, Bacal F, Ferraz AS, Albuquerque D, Rodrigues D, et al. Updating of the Brazilian guideline for chronic heart failure - 2012. Arq Bras Cardiol. 2012:98(1 Suppl 1):1-33. 1101. Beemath A, Stein PD, Skaf E, Al Sibae MR, Alesh I. Risk of venous thromboembolism in patients hospitalizedwith heart failure. Am J Cardiol. 2006;98(6):793-5. 1102. Turpie AG. Thrombosis prophylaxis in the acutely ill medical patient: insights from the prophylaxis in MEDical patients with ENOXaparin (MEDENOX) trial. Am J Cardiol. 2000;86(12B):48M-52M. 1103. Jain P, Massie BM, Gattis WA, Klein L, Gheorghiade M. Current medical treatment for the exacerbation of chronic heart failure resulting in hospitalization. AmHeart J. 2003;145(2 Suppl):S3-17. 1104. Thackray S, Eastaugh J, Freemantle N, Cleland JG. The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure: a meta-regression analysis. Eur J Heart Fail. 2002;4(4):515-29. 1105. Felker GM, Benza RL, Chandler AB, Leimberger JD, Cuffe MS, Califf RM, et al; OPTIME-CHF Investigators. Heart failure etiology and response to milrinone in decompensated heart failure: results from theOPTIME-CHF study. J Am Coll Cardiol. 2003;41(6):997-1003. 1106. Follath F, Cleland JG, Just H, Papp JG, Scholz H, Peuhkurinen K, et al; Steering Committee and Investigators of the Levosimendan Infusion versus Dobutamine (LIDO) Study. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomized double-blind trial. Lancet. 2002;360(9328):196-202. 1107. Stevenson LW, Pagani FD, Young JB, Jessup M, Miller L, Kormos RL, et al. INTERMACS profiles of advanced heart failure: the current picture. J Heart Lung Transplant. 2009;28(6):535-41. 1108. RihalCS,NaiduSS,GivertzMM,SzetoWY,Burke JA,KapurNK,etal.2015 SCAI/ACC/HFSA/STS Clinical Expert Consensus Statement on the use of percutaneous mechanical circulatory support devices in cardiovascular care endorsed by the AHA, the Cardiological Society of India and Sociedad Latino Americana de Cardiologia - Intervention; Affirmation of value by the Canadian Association of Interventional Cardiology - Association Canadienne de Cardiologie d'intervention. J AmColl Cardiol. 2015;65(19):e7-e26. 1109. Levy B, BastienO, KarimB, CariouA, Chouihed T, Combes A, et al. Experts' recomendations for the management of adult patients with cardiogenic shock. Ann Intensive Care. 2015;5(1):52. 1110. Bernoche C, Kopel L, Lopes L, Geisler D, Macatrão-Costa MF, Lage SG. Atualização no manejo clínico do choque cardiogênico. Rev Soc Cardiol Estado Sao Paulo. 2015;26(1):14-20. 1111. Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, et al; IABP-SHOCK II Trial Investigators. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012;367(14):1287-96. 1112. Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, et al; Intraaortic Balloon Pump in cardiogenic shock II (IABP-SHOCK II) trial investigators. Intraaortic balloon counterpulsations in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 months results of a randomized open-label trial. Lancet. 2013;382(9905):1638-45. 1113. Bezerra CG, AdamEL, BaptistaML, Ciambelli GS, Kopel L, Bernoche C, et al. Aortic counterpulsation therapy in patients with advanced heart failure: analysis of the TBRIDGE Registry. Arq Bras Cardiol. 2016;106(1):26-32. 1114. Extracorporeal Life Support Organization (ECLS) Registry Report. [Cited in 2017 Dec 10. Available from: https://www.elso.org/Registry/Statistics/ InternationalSummary.aspx 1115. Stevenson LW, Pagani FD, Young JB, Jessup M, Miller L, Kormos RL, et al. INTERMACS profiles of advanced heart failure: the current picture. J Heart Lung Transplant. 2009;28(6):535-41. 1116. Kirklin JK, Naftel DC, Stevenson LW, Kormos RL, Pagani FD, Miller MA, et al. INTERMACS database for durable devices for circulatory support: first annual report. J Heart Lung Transplant. 2008;27(10):1065-72. 1117. Nomenclature and criteria for diagnosis of diseases of the heart and blood vessels. The Criteria Committee of the NewYork Heart Association. Boston: New York Association; 1992. 1118. Hunt SA, AbrahamWT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al; American College of Cardiology; American Heart Association Task Force on Practice Guidelines; American College of Chest Physicians; International Society for Heart and Lung Transplantation; Heart Rhythm Society. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force onPracticeGuidelines (WritingCommitteetoUpdatethe2001Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005;112(12):e154-235. 1119. Schmidt M, Burrell A, Roberts L, Bailey M, Sheldrake J, Rycus PT, et al. Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno?arterial?ECMO (SAVE)?score. Eur Heart J. 2015;36(33):2246-56. 1120. Muller G, Flecher E, Lebreton G, Luyt CE, Trouillet JL, Bréchot N, et al. The ENCOURAGEmortality risk score and analysis of long-termoutcomes after VA-ECMO for acute myocardial infarction with cardiogenic shock. Intensive Care Med. 2016;42(3):370-8. 1121. Seldinger SI. Catheter replacement of the needle in percutaneous arteriography: A new technique. Acta Radiologica. 1953;39(5):368-76. 1122. Abrams D, Combes A, Brodie D. Extracorporeal MembraneOxygenation in Cardiopulmonary Disease in Adults. J Am Coll Cardiol. 2014;63(25 Pt A):2769-78. 656